Huntingtin interacting proteins are genetic modifiers of neurodegeneration

PLoS Genetics

Volumn 3, Issue 5, 2007, Pages 689-708

  Kaltenbach, Linda S ^a,e   Romero, Eliana ^b   Becklin, Robert R ^a   Chettier, Rakesh ^a   Bell, Russell ^a   Phansalkar, Amit ^a   Strand, Andrew ^c   Torcassi, Cameron ^d   Savage, Justin ^a   Hurlburt, Anthony ^a   Cha, Guang Ho ^b   Ukani, Lubna ^b   Chepanoske, Cindy Lou ^a   Zhen, Yuejun ^a   Sahasrabudhe, Sudhir ^a   Olson, James ^c   Kurschner, Cornelia ^a   Ellerby, Lisa M ^d   Peltier, John M ^a   Botas, Juan ^b   Hughes, Robert E ^a,d   more..

^a Prolexys Pharmaceuticals   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^e DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; HUNTINGTIN INTERACTING PROTEIN; POLYGLUTAMINE; PROTEIN; UNCLASSIFIED DRUG; HD PROTEIN, HUMAN; HUNTINGTON PROTEIN, MOUSE; NERVE PROTEIN; NUCLEAR PROTEIN; PEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DNA MODIFICATION; DROSOPHILA; EXPERIMENTAL MODEL; GENETIC COMPLEMENTATION; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; HUNTINGTON CHOREA; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TWO HYBRID SYSTEM; UNINDEXED SEQUENCE; VALIDATION STUDY; ANIMAL; BIOLOGICAL MODEL; DROSOPHILA MELANOGASTER; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PROTEIN BINDING; REPRODUCIBILITY;

ANIMALS; DROSOPHILA MELANOGASTER; HUMANS; IMMUNOPRECIPITATION; MICE; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; REPRODUCIBILITY OF RESULTS;

EID: 34249715853     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.0030082     Document Type: Article

References (68)

1. Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep 5: 958-963.
2. Hickey MA, Chesselet MF (2003) The use of transgenic and knock-in mice to study Huntington's disease. Cytogenet Genome Res 100: 276-286.
3. Zoghbi HY, Botas J (2002) Mouse and fly models of neurodegeneration. Trends Genet 18: 463-471.
4. Driscoll M, Gerstbrein B (2003) Dying for a cause: Invertebrate genetics takes on human neurodegeneration. Nat Rev Genet 4: 181-194.
5. DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, et al. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14: 1075-1081.
6. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90: 537-548.
7. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, et al. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 19: 148-154.
8. Perez MK, Paulson HL, Pendse SJ, Saionz SJ, Bonini NM, et al. (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol 143: 1457-1470.
9. Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D, Housman D (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A 96: 11404-11409.
10. Suhr ST, Senut MC, Whitelegge JP, Faull KF, Cuizon DB, et al. (2001) Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol 153: 283-294.
11. Nucifora FC Jr., Sasaki M, Peters MF, Huang H, Cooper JK, et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291: 2423-2428.
12. Boutell JM, Thomas P, Neal JW, Weston VJ, Duce J, et al. (1999) Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum Mol Genet 8: 1647-1655.
13. Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, et al. (2000) The Huntington's disease protein interacts with p53 and CREBbinding protein and represses transcription. Proc Natl Acad Sci U S A 97: 6763-6768.
14. Schaffar G, Breuer P, Boteva R, Behrends C, Tzvetkov N, et al. (2004) Cellular toxicity of polyglutamine expansion proteins: Mechanism of transcription factor deactivation. Mol Cell 15: 95-105.
15. Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, et al. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296: 2238-2243.
16. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413: 739-743.
17. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431: 805-810.
18. Slow EJ, Graham RK, Osmand AP, Devon RS, Lu G, et al. (2005) Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci U S A 102: 11402-11407.
19. Zala D, Benchoua A, Brouillet E, Perrin V, Gaillard MC, et al. (2005) Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiol Dis 20: 785-798.
20. MacDonald ME (2003) Huntingtin: Alive and well and working in middle management. Sci STKE 2003: pe48.
21. Andrade MA, Bork P (1995) HEAT repeats in the Huntington's disease protein. Nat Genet 11: 115-116.
22. Harjes P, Wanker EE (2003) The hunt for huntingtin function: Interaction partners tell many different stories. Trends Biochem Sci 28: 425-433.
23. Li SH, Li XJ (2004) Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet 20: 146-154.
24. Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: An alternative approach to Huntington's disease. Nat Rev Neurosci 6: 919-930.
25. Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, et al. (2002) Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415: 141-147.
26. Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, et al. (2002) Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415: 180-183.
27. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, et al. (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci U S A 98: 4569-4574.
28. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, et al. (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403: 623-627.
29. Lim J, Hao T, Shaw C, Patel AJ, Szabo G, et al. (2006) A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125: 801-814.
30. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, et al. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437: 1173-1178.
31. Lacount DJ, Vignali M, Chettier R, Phansalkar A, Bell R, et al. (2005) A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 438: 103-107.
32. James P, Halladay J, Craig EA (1996) Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144: 1425-1436.
33. Sprinzak E, Sattath S, Margalit H (2003) How reliable are experimental protein-protein interaction data? J Mol Biol 327: 919-923.
34. von Mering C, Krause R, Snel B, Cornell M, Oliver SG, et al. (2002) Comparative assessment of large-scale data sets of protein-protein interactions. Nature 417: 399-403.
35. Waelter S, Scherzinger E, Hasenbank R, Nordhoff E, Lurz R, et al. (2001) The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptinbinding protein involved in receptor-mediated endocytosis. Hum Mol Genet 10: 1807-1817.
36. Burke JR, Enghild JJ, Martin ME, Jou YS, Myers RM, et al. (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 2: 347-350.
37. Laviolette MJ, Nunes P, Peyre JB, Aigaki T, Stewart BA (2005) A genetic screen for suppressors of Drosophila NSF2 neuromuscular junction overgrowth. Genetics 170: 779-792.
38. Singh A, Chan J, Chern JJ, Choi KW (2005) Genetic interaction of Lobe with its modifiers in dorsoventral patterning and growth of the Drosophila eye. Genetics 171: 169-183.
39. Kazemi-Esfarjani P, Benzer S (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science 287: 1837-1840.
40. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, et al. (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408: 101-106.
41. Brunger AT (2005) Structure and function of SNARE and SNARE-interacting proteins. Q Rev Biophys 38: 1-47.
42. Sudhof TC (2004) The synaptic vesicle cycle. Annu Rev Neurosci 27: 509-547.
43. Velier J, Kim M, Schwarz C, Kim TW, Sapp E, et al. (1998) Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp Neurol 152: 34-40.
44. Qin ZH, Wang Y, Sapp E, Cuiffo B, Wanker E, et al. (2004) Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J Neurosci 24: 269-281.
45. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, et al. (2006) BioGRID: A general repository for interaction datasets. Nucleic Acids Res 34: D535-D539.
46. Mishra GR, Suresh M, Kumaran K, Kannabiran N, Suresh S, et al. (2006) Human protein reference database-2006 update. Nucleic Acids Res 34: D411-D414.
47. Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK, et al. (2003) Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 13: 2363-2371.
48. Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, et al. (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12: 1555-1567.
49. Bae BI, Hara MR, Cascio MB, Wellington CL, Hayden MR, et al. (2006) Mutant huntingtin: Nuclear translocation and cytotoxicity mediated by GAPDH. Proc Natl Acad Sci U S A 103: 3405-3409.
50. Venkatraman P, Wetzel R, Tanaka M, Nukina N, Goldberg AL (2004) Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol Cell 14: 95-104.
51. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, et al. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia. Ann Neurol 41: 646-653.
52. Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, et al. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5: 731-736.
53. Tang TS, Tu H, Chan EY, Maximov A, Wang Z, et al. (2003) Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39: 227-239.
54. Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, et al. (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40: 25-40.
55. Li JY, Plomann M, Brundin P (2003) Huntington's disease: A synaptopathy? Trends Mol Med 9: 414-420.
56. Swayne LA, Chen L, Hameed S, Barr W, Charlesworth E, et al. (2005) Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels. Mol Cell Neurosci 30: 339-351.
57. Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, et al. (2004) A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol Cell 15: 853-865.
58. Faber PW, Barnes GT, Srinidhi J, Chen J, Gusella JF, et al. (1998) Huntingtin interacts with a family of WW domain proteins. Hum Mol Genet 7: 1463-1474.
59. Kitamura A, Kubota H, Pack CG, Matsumoto G, Hirayama S, et al. (2006) Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat Cell Biol 8: 1163-1170.
60. Tam S, Geller R, Spiess C, Frydman J (2006) The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat Cell Biol 8: 1155-1162.
61. Hudson JR Jr., Dawson EP, Rushing KL, Jackson CH, Lockshon D, et al. (1997) The complete set of predicted genes from Saccharomyces cerevisiae in a readily usable form. Genome Res 7: 1169-1173.
62. Peltier JM, Askovic S, Becklin RR, Chepanoske CL, Ho Y-SJ, et al. (2004) An integrated strategy for the discovery of drug targets by the analysis of protein-protein interactions. Int J Mass Spectrom 238: 119-130.
63. Pappin DJ, Hojrup P, Bleasby AJ (1993) Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 3: 327-332.
64. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567.
65. Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401-415.
66. Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, et al. (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8: 397-407.
67. Yu ZX, Li SH, Evans J, Pillarisetti A, Li H, et al. (2003) Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J Neurosci 23: 2193-2202.
68. Ganetzky B, Flanagan JR (1978) On the relationship between senescence and age-related changes in two wild-type strains of Drosophila melanogaster. Exp Gerontol 13: 189-196.